Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program
Authors:
- 28 July 2005
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 25 (8) , 635-640
Abstract
Objective(s) To estimate weight and ethnic group correction factors for first‐trimester screening markers. Methods Ethnic‐specific median MoM free beta hCG and pregnancy associated plasma protein A (PAPP‐A) and delta nuchal translucency values were calculated for cohorts of maternal weight (20 lb each) using data from 51 206 patients undergoing first‐trimester screening. False‐positive rates for Down syndrome and trisomy 18 were evaluated both prior to and after weight and ethnicity adjustment. Results Free beta hCG and PAPP‐A significantly decreased with increasing maternal weight while nuchal translucency increased by a clinically insignificant amount. For free beta hCG the regression formula indicated that after accounting for maternal weight MoM values were 16% higher for African Americans, 6% higher for Asians and 9% lower for Hispanics compared to Caucasians (p < 0.001, p = 0.001, p < 0.001, respectively) but there was no significant difference for Asian Indians. For PAPP‐A, MoM values were 35% higher for African Americans (p < 0.001) but were not significantly different for the other ethnic groups compared to Caucasians. Down syndrome false‐positive rates did not vary with maternal weight prior to (p = 0.291) or after weight adjustment of biochemistry (p = 0.054). Trisomy 18 false‐positive rates varied significantly with weight both before (OR = 1.455 per 20‐pound increase, p < 0.001) and after (OR = 1.066 per 20‐pound increase, p = 0.01) weight adjustment of biochemistry; however, the odds ratio was greatly reduced after weight adjustment. Conclusion(s) The first‐trimester screening markers, free beta hCG, PAPP‐A and nuchal translucency vary with maternal weight and ethnicity. Adjustment of free beta hCG and PAPP‐A is indicated but adjustment of nuchal translucency results may not be necessary. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 11 references indexed in Scilit:
- First-Trimester Screening for Trisomies 21 and 18New England Journal of Medicine, 2003
- Maternal weight correction of maternal serum PAPP‐A and free β‐hCG MoM when screening for trisomy 21 in the first trimester of pregnancyPrenatal Diagnosis, 2003
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnanciesUltrasound in Obstetrics & Gynecology, 2002
- The effect of ethnic origin on nuchal translucency at 10–14 weeks of gestationPrenatal Diagnosis, 2002
- Co-variables in first trimester maternal serum screeningPrenatal Diagnosis, 2000
- Influence of ethnic origin on nuchal translucency screening for Down's syndromeUltrasound in Obstetrics & Gynecology, 1998
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucencyUltrasound in Obstetrics & Gynecology, 1997
- EFFECT OF ALLOWING FOR ETHNIC GROUP IN PRENATAL SCREENING FOR DOWN'S SYNDROMEPrenatal Diagnosis, 1996